leadf
logo-loader
ASX:RGS

Regeneus Ltd

Receive alerts
Market:
ASX
Market Cap:
$33.03 m
Price
0.11 AUD
Change
4.76%
52 weeks high
0.20
52 weeks low
0.05

In brief

Regeneus Ltd (ASX:RGS) is a clinical-stage regenerative medicine company developing a portfolio of cell therapies with a focus on musculoskeletal disease, oncology and dermatology.